PT Phapros, Tbk (PEHA.JK)
IDR 280.0
(0.72%)
IDR 280.0
(0.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 533.85 Billion IDR | -8.51% |
| 2022 | 583.49 Billion IDR | 12.31% |
| 2021 | 519.52 Billion IDR | -0.76% |
| 2020 | 523.48 Billion IDR | -14.11% |
| 2019 | 609.48 Billion IDR | 4.54% |
| 2018 | 583.02 Billion IDR | 3.15% |
| 2017 | 565.23 Billion IDR | 24.0% |
| 2016 | 455.82 Billion IDR | 17.35% |
| 2015 | 388.42 Billion IDR | 16.31% |
| 2014 | 333.95 Billion IDR | 4.0% |
| 2013 | 321.12 Billion IDR | 0.05% |
| 2012 | 320.96 Billion IDR | 11.95% |
| 2011 | 286.69 Billion IDR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 90.09 Billion IDR | 23.65% |
| 2024 Q3 | 95.47 Billion IDR | 5.97% |
| 2024 Q1 | 72.86 Billion IDR | -47.86% |
| 2023 Q3 | 100.47 Billion IDR | -30.39% |
| 2023 Q2 | 144.33 Billion IDR | 7.38% |
| 2023 Q1 | 134.41 Billion IDR | -14.25% |
| 2023 Q4 | 139.75 Billion IDR | 39.09% |
| 2023 FY | 533.85 Billion IDR | -8.51% |
| 2022 FY | 583.49 Billion IDR | 12.31% |
| 2022 Q3 | 150.4 Billion IDR | 6.74% |
| 2022 Q2 | 140.9 Billion IDR | 4.04% |
| 2022 Q1 | 135.44 Billion IDR | -2.39% |
| 2022 Q4 | 156.74 Billion IDR | 4.22% |
| 2021 Q1 | 119.17 Billion IDR | -21.91% |
| 2021 FY | 519.52 Billion IDR | -0.76% |
| 2021 Q4 | 138.76 Billion IDR | -2.62% |
| 2021 Q3 | 142.49 Billion IDR | 19.65% |
| 2021 Q2 | 119.09 Billion IDR | -0.07% |
| 2020 Q4 | 152.62 Billion IDR | 21.59% |
| 2020 FY | 523.48 Billion IDR | -14.11% |
| 2020 Q1 | 126.21 Billion IDR | -30.61% |
| 2020 Q2 | 119.13 Billion IDR | -5.61% |
| 2020 Q3 | 125.51 Billion IDR | 5.36% |
| 2019 Q3 | 131.21 Billion IDR | -33.55% |
| 2019 Q4 | 181.88 Billion IDR | 38.61% |
| 2019 FY | 609.48 Billion IDR | 4.54% |
| 2019 Q2 | 197.45 Billion IDR | 99.6% |
| 2019 Q1 | 98.92 Billion IDR | -42.49% |
| 2018 Q4 | 172.01 Billion IDR | -3.65% |
| 2018 Q1 | 85.13 Billion IDR | -55.8% |
| 2018 Q2 | 147.35 Billion IDR | 73.07% |
| 2018 FY | 583.02 Billion IDR | 3.15% |
| 2018 Q3 | 178.52 Billion IDR | 21.15% |
| 2017 Q4 | 192.62 Billion IDR | 0.0% |
| 2017 FY | 565.23 Billion IDR | 24.0% |
| 2016 FY | 455.82 Billion IDR | 17.35% |
| 2015 FY | 388.42 Billion IDR | 16.31% |
| 2014 FY | 333.95 Billion IDR | 4.0% |
| 2013 FY | 321.12 Billion IDR | 0.05% |
| 2012 FY | 320.96 Billion IDR | 11.95% |
| 2011 FY | 286.69 Billion IDR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 942.41 Billion IDR | 43.353% |
| PT Merck Tbk | 391.72 Billion IDR | -36.282% |
| PT Pyridam Farma Tbk | 282.01 Billion IDR | -89.3% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 2018.69 Billion IDR | 73.555% |
| PT Tempo Scan Pacific Tbk | 4513.76 Billion IDR | 88.173% |